64K Cellssense debuts at CIIE with Asia expansion push

64K Cellssense will make its first appearance as an invited exhibitor at the ninth China International Import Expo in Shanghai from Nov. 5-10, 2026. The Swiss-rooted longevity brand is using the platform to showcase its anti-aging portfolio, delivery technology and to pursue professional partnerships across Asia.

Why it matters: - 64K Cellssense is using one of China’s biggest import trade shows to expand its visibility in Asia. - The CIIE audience includes international companies and professional buyers across consumer goods and healthcare. - The brand’s strategy ties product marketing to professional channel development, not just consumer exposure.

What happened: - 64K Cellssense will debut as an invited exhibitor at the ninth China International Import Expo in Shanghai from Nov. 5-10, 2026. - The Swiss-rooted longevity brand is presenting its anti-aging innovation approach and product portfolio at the National Exhibition and Convention Center in Shanghai. - The company is using the event to advance its development in Asia and build professional partnerships.

The details: - CIIE brought together 4,108 companies from 138 countries and regions in its 2025 Enterprise & Business Exhibition, according to the CIIE Bureau. - Earlier CIIE editions featured Swiss companies Roche and Nestlé, along with L’Oréal and other international groups. - 64K Cellssense says nutrition innovation includes how nutrients are protected, released and used, not only ingredient selection. - The brand says that delivery science helps shape how it translates scientific research into products for everyday healthy aging. - The company is showcasing products for a range of everyday needs alongside the science behind them. - The presentation connects ingredient selection, delivery science and formulation design to the brand’s approach to healthy aging. - 64K Cellssense’s scientific approach centers on its exclusive MPNutria® nutrient delivery technology. - The MPNutria® platform is built on more than a decade of research. - The brand’s collaboration with Clinique Eden Suisse, a professional health and wellness institution in the Canton of Vaud, brings Swiss clinical practice insights into discussions of anti-aging needs and research priorities.

Between the lines: - The CIIE debut suggests 64K Cellssense is positioning itself as a science-led brand rather than a pure consumer wellness label. - The focus on professional partnerships hints at a longer-term market entry strategy across Asia. - The emphasis on Swiss clinical and research credentials appears designed to support trust in a crowded longevity category.

What's next: - 64K Cellssense expects the Shanghai exhibition to help identify local partners and shape its longer-term development in the region. - The brand plans to use its existing channel presence in Switzerland, the United States, mainland China, Hong Kong and South Korea as a base for further expansion across Asia. - Discussions at CIIE are meant to connect the company’s research-led approach with local market needs.

The bottom line: - 64K Cellssense is turning its CIIE debut into a regional growth play, using science, clinical ties and delivery technology to court Asia’s professional health channels.